article thumbnail

The future of CNS drug development: signs of real progress

Drug Target Review

Viral vectors use a virus’s blueprint to deliver genetic material into cells. To qualify for this designation, a drug candidate must meet the definition of regenerative medicine therapy, intend to treat or cure a serious condition, and be supported by preliminary clinical evidence that indicates it can address the clinical need.

article thumbnail

PRITELIVIR MESYLATE

New Drug Approvals

1428321-10-1 Pritelivir mesylate is an antiviral drug currently under development, specifically targeting herpes simplex virus types 1 and 2 (HSV-1 and HSV-2). Pritelivir (development codes AIC316 or BAY 57-1293 ) is a direct-acting antiviral drug in development for the treatment of herpes simplex virus infections (HSV).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

WHO Scientific Group Publishes Findings on COVID-19’s Origins

The Pharma Data

The group, made up of virologists, epidemiologists, public health professionals, and biosafety specialists, has been working for over three years to shed light on one of the most pressing questions in modern global health: how did SARS-CoV-2, the virus responsible for COVID-19, first infect humans?

article thumbnail

The Definition of “Fully Vaccinated” Needs to Change

Eye on FDA

We are long gone from the days of being threatened by a rampant Alpha virus to having several successive variants. It would seem that Omicron has rendered that definition outmoded. The COVID-19 pandemic is a rapidly changing landscape. We now have multiple vaccines – mRNA and traditional in the U.S.

article thumbnail

Roche signs definitive share purchase agreement with long-term partner TIB.

The Pharma Data

Roche today announced that it has signed a definitive share purchase agreement to acquire 100% of the outstanding shares of the TIB Molbiol Group. The acquisition enables Roche to further expand the portfolio of currently over 45 CE-IVD assays and more than 100 research use assays on Roche`s LightCycler PCR instruments.

article thumbnail

#WhyIScience Q&A: A process development lead returns to her research roots

Broad Institute

After graduating, Teixeira-Soldano discovered new definitions of development that intrigued her. In this #WhyIScience, she talks about her role as a COVID-19 lab technician, how she transitioned into a process development role, and how her definition of development has changed throughout her career.

article thumbnail

CDC says nearly 11,000 Americans have been exposed to COVID-19 on flights

The Pharma Data

The agency says that a significant amount of the people exposed fell ill with the virus, but there could be more cases due to incomplete contact tracing information and the virus incubating over several days. This follows other studies in Asia and Europe where scientists believe the virus has spread on commercial flights.